PNC Financial Services Group
IART icon

PNC Financial Services Group’s Integra LifeSciences IART Stock Holding History

PNC Financial Services Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Sell
15,123
-1,662
-10% -$18.2K ﹤0.01% 2572
2025
Q4 		$208K Hold
16,785
– – ﹤0.01% 2283
2025
Q3 		$241K Buy
16,785
+67
+0.4% +$918 ﹤0.01% 2174
2025
Q2 		$205K Sell
16,718
-3,643
-18% -$52.9K ﹤0.01% 2185
2025
Q1 		$448K Buy
20,361
+606
+3% +$14.3K ﹤0.01% 1599
2024
Q4 		$448K Buy
19,755
+4,967
+34% +$108K ﹤0.01% 1623
2024
Q3 		$269K Sell
14,788
-5,395
-27% -$125K ﹤0.01% 1975
2024
Q2 		$588K Buy
20,183
+6,941
+52% +$206K ﹤0.01% 1402
2024
Q1 		$469K Sell
13,242
-255
-2% -$10.2K ﹤0.01% 1574
2023
Q4 		$588K Sell
13,497
-307
-2% -$12.1K ﹤0.01% 1422
2023
Q3 		$527K Sell
13,804
-7,166
-34% -$301K ﹤0.01% 1446
2023
Q2 		$862K Sell
20,970
-2,022
-9% -$97.3K ﹤0.01% 1222
2023
Q1 		$1.32M Buy
22,992
+124
+0.5% +$6.99K ﹤0.01% 1011
2022
Q4 		$1.28M Sell
22,868
-1,838
-7% -$93.6K ﹤0.01% 1016
2022
Q3 		$1.05M Buy
24,706
+1,831
+8% +$93.8K ﹤0.01% 1106
2022
Q2 		$1.24M Sell
22,875
-504
-2% -$30.3K ﹤0.01% 1048
2022
Q1 		$1.5M Sell
23,379
-3,755
-14% -$247K ﹤0.01% 1046
2021
Q4 		$1.82M Buy
27,134
+506
+2% +$34.2K ﹤0.01% 999
2021
Q3 		$1.82M Buy
26,628
+591
+2% +$41.8K ﹤0.01% 945
2021
Q2 		$1.78M Buy
26,037
+339
+1% +$24K ﹤0.01% 968
2021
Q1 		$1.77M Buy
25,698
+1,077
+4% +$73K ﹤0.01% 926
2020
Q4 		$1.6M Sell
24,621
-190
-0.8% -$10.2K ﹤0.01% 931
2020
Q3 		$1.17M Sell
24,811
-4,260
-15% -$203K ﹤0.01% 980
2020
Q2 		$1.37M Buy
29,071
+2,467
+9% +$121K ﹤0.01% 915
2020
Q1 		$1.19M Sell
26,604
-1,344
-5% -$70.5K ﹤0.01% 905
2019
Q4 		$1.63M Sell
27,948
-21,896
-44% -$1.3M ﹤0.01% 876
2019
Q3 		$2.99M Sell
49,844
-12,288
-20% -$732K ﹤0.01% 820
2019
Q2 		$3.47M Buy
62,132
+4,368
+8% +$225K ﹤0.01% 819
2019
Q1 		$3.22M Sell
57,764
-972
-2% -$49.5K ﹤0.01% 874
2018
Q4 		$2.65M Sell
58,736
-1,308
-2% -$71.8K ﹤0.01% 902
2018
Q3 		$3.96M Buy
60,044
+2,300
+4% +$143K ﹤0.01% 832
2018
Q2 		$3.72M Sell
57,744
-1,026
-2% -$63.5K ﹤0.01% 842
2018
Q1 		$3.25M Sell
58,770
-3,341
-5% -$175K ﹤0.01% 875
2017
Q4 		$2.97M Buy
62,111
+756
+1% +$37K ﹤0.01% 909
2017
Q3 		$3.1M Buy
61,355
+37,444
+157% +$1.92M ﹤0.01% 876
2017
Q2 		$1.3M Sell
23,911
-274
-1% -$13.1K ﹤0.01% 1157
2017
Q1 		$1.02M Buy
24,185
+615
+3% +$26.3K ﹤0.01% 1285
2016
Q4 		$1.01M Sell
23,570
-3,818
-14% -$155K ﹤0.01% 1280
2016
Q3 		$1.13M Sell
27,388
-1,964
-7% -$82.3K ﹤0.01% 1221
2016
Q2 		$1.17M Sell
29,352
-1,320
-4% -$47.5K ﹤0.01% 1198
2016
Q1 		$1.03M Buy
30,672
+7,102
+30% +$221K ﹤0.01% 1240
2015
Q4 		$799K Sell
23,570
-5,152
-18% -$161K ﹤0.01% 1304
2015
Q3 		$855K Buy
28,722
+2,711
+10% +$84.8K ﹤0.01% 1289
2015
Q2 		$716K Buy
26,011
+1,414
+6% +$37.7K ﹤0.01% 1432
2015
Q1 		$619K Buy
24,597
+604
+3% +$14.3K ﹤0.01% 1498
2014
Q4 		$532K Buy
23,993
+3,748
+19% +$76K ﹤0.01% 1528
2014
Q3 		$411K Sell
20,245
-3,425
-14% -$68.2K ﹤0.01% 1596
2014
Q2 		$456K Hold
23,670
– – ﹤0.01% 1490
2014
Q1 		$445K Buy
23,670
+184
+0.8% +$3.55K ﹤0.01% 1463
2013
Q4 		$458K Sell
23,486
-2,515
-10% -$46.1K ﹤0.01% 1437
2013
Q3 		$428K Buy
26,001
+68
+0.3% +$1.09K ﹤0.01% 1441
2013
Q2 		$388K Buy
+25,933
New +$380K ﹤0.01% 1418

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PNC Financial Services Group's IART Position: Q1 2026 in Review

PNC Financial Services Group reduced its Integra LifeSciences (IART) stake by 9.9% in Q1 2026, selling an estimated $18.2K and leaving 15,123 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

PNC Financial Services Group first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.96M in Q3 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • PNC Financial Services Group held 15,123 shares of Integra LifeSciences worth $142K as of Q1 2026.
  • PNC Financial Services Group sold 1,662 Integra LifeSciences shares in Q1 2026, an estimated $18.2K.
  • Integra LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2572 holding.
  • PNC Financial Services Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Integra LifeSciences position peaked at $3.96M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.